Bgm (BGM) Current Assets (2019 - 2025)
Bgm's (BGM) quarterly Current Assets came in at $51.5 million in Q3 2025, up 73.15% year-on-year from $29.8 million in Q3 2024, and up 20.04% on a QoQ basis from $42.9 million in Q1 2025.
Bgm (BGM) Current Assets (2019 - 2025) Analysis & Trends
Bgm (BGM) has 7 years of Current Assets data on file, last reported at $51.5 million in Q3 2025.
- On a quarterly basis, Current Assets rose 73.15% year-over-year to $51.5 million in Q3 2025; TTM through Sep 2025 was $51.5 million, a 73.15% increase from a year earlier, with the FY2025 full-year figure at $51.5 million, up 73.15% from the prior year.
- Current Assets for Q3 2025 stood at $51.5 million, up from $42.9 million in the prior quarter.
- Over the last five years, Current Assets for BGM reached as high as $58505.6 billion in Q1 2021 and fell as low as $29.8 million in Q3 2024.
- Historically, Current Assets has averaged $12852.2 billion across 5 years, with a median of $41.7 million in 2021.
- Across the five-year window, Current Assets slumped 100.0% in 2024 and jumped 73.15% in 2025, its largest moves.
- Year by year, Current Assets stood at $40.4 million in 2021, then fell by 25.59% to $30.0 million in 2022, then grew by 14.91% to $34.5 million in 2023, then decreased by 13.74% to $29.8 million in 2024, then soared by 73.15% to $51.5 million in 2025.
- Per Business Quant data, the three most recent Current Assets figures were $51.5 million in Q3 2025, $42.9 million in Q1 2025, and $29.8 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 2.87 Bn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | 6.53 Mn |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Bgm | 33.55 Mn | 23.73 Mn | - | 51.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 51.55 Mn |
| Mar 31, 2025 | 42.94 Mn |
| Sep 30, 2024 | 29.77 Mn |
| Mar 31, 2024 | 33.33 Mn |
| Sep 30, 2023 | 34.51 Mn |
| Mar 31, 2023 | 27,079.30 Bn |
| Sep 30, 2022 | 30.03 Mn |
| Mar 31, 2022 | 42,936.45 Bn |
| Sep 30, 2021 | 40.37 Mn |
| Mar 31, 2021 | 58,505.61 Bn |
| Sep 30, 2020 | 37.52 Mn |
| Sep 30, 2019 | 24.97 Mn |